Eyes acquisitions despite takeover

"We will continue to make acquisitions. As a firm, we would continue to grow and I think we need to separate ownership and management. Management of the company will remain same," Malvinder Mohan Singh, CEO and MD, Ranbaxy, said in an interview to a news channel